• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

认知未受损个体认知轨迹的分类与预测

Classification and prediction of cognitive trajectories of cognitively unimpaired individuals.

作者信息

Kim Young Ju, Kim Si Eun, Hahn Alice, Jang Hyemin, Kim Jun Pyo, Kim Hee Jin, Na Duk L, Chin Juhee, Seo Sang Won

机构信息

Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Neuroscience Center, Samsung Medical Center, Seoul, Republic of Korea.

出版信息

Front Aging Neurosci. 2023 Mar 13;15:1122927. doi: 10.3389/fnagi.2023.1122927. eCollection 2023.

DOI:10.3389/fnagi.2023.1122927
PMID:36993907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10040799/
Abstract

OBJECTIVES

Efforts to prevent Alzheimer's disease (AD) would benefit from identifying cognitively unimpaired (CU) individuals who are liable to progress to cognitive impairment. Therefore, we aimed to develop a model to predict cognitive decline among CU individuals in two independent cohorts.

METHODS

A total of 407 CU individuals from the Alzheimer's Disease Neuroimaging Initiative (ADNI) and 285 CU individuals from the Samsung Medical Center (SMC) were recruited in this study. We assessed cognitive outcomes by using neuropsychological composite scores in the ADNI and SMC cohorts. We performed latent growth mixture modeling and developed the predictive model.

RESULTS

Growth mixture modeling identified 13.8 and 13.0% of CU individuals in the ADNI and SMC cohorts, respectively, as the "declining group." In the ADNI cohort, multivariable logistic regression modeling showed that increased amyloid-β (Aβ) uptake (β [SE]: 4.852 [0.862], < 0.001), low baseline cognitive composite scores (β [SE]: -0.274 [0.070], < 0.001), and reduced hippocampal volume (β [SE]: -0.952 [0.302], = 0.002) were predictive of cognitive decline. In the SMC cohort, increased Aβ uptake (β [SE]: 2.007 [0.549], < 0.001) and low baseline cognitive composite scores (β [SE]: -4.464 [0.758], < 0.001) predicted cognitive decline. Finally, predictive models of cognitive decline showed good to excellent discrimination and calibration capabilities (C-statistic = 0.85 for the ADNI model and 0.94 for the SMC model).

CONCLUSION

Our study provides novel insights into the cognitive trajectories of CU individuals. Furthermore, the predictive model can facilitate the classification of CU individuals in future primary prevention trials.

摘要

目的

识别有认知功能下降倾向的认知未受损(CU)个体,将有助于预防阿尔茨海默病(AD)的工作。因此,我们旨在开发一个模型,以预测两个独立队列中CU个体的认知衰退情况。

方法

本研究招募了来自阿尔茨海默病神经影像倡议(ADNI)的407名CU个体和来自三星医疗中心(SMC)的285名CU个体。我们在ADNI和SMC队列中使用神经心理学综合评分评估认知结果。我们进行了潜在增长混合模型分析并开发了预测模型。

结果

增长混合模型分别在ADNI和SMC队列中识别出13.8%和13.0%的CU个体为“衰退组”。在ADNI队列中,多变量逻辑回归模型显示,淀粉样蛋白-β(Aβ)摄取增加(β[标准误]:4.852[0.862],P<0.001)、基线认知综合评分较低(β[标准误]:-0.274[0.070],P<0.001)以及海马体积减小(β[标准误]:-0.952[0.302],P=0.002)可预测认知衰退。在SMC队列中,Aβ摄取增加(β[标准误]:2.007[0.549],P<0.001)和基线认知综合评分较低(β[标准误]:-4.464[0.758],P<0.001)可预测认知衰退。最后,认知衰退预测模型显示出良好到出色的区分能力和校准能力(ADNI模型的C统计量为0.85,SMC模型的C统计量为0.94)。

结论

我们的研究为CU个体的认知轨迹提供了新的见解。此外,该预测模型有助于在未来的一级预防试验中对CU个体进行分类。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd2/10040799/dced02fd4233/fnagi-15-1122927-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd2/10040799/6f6e5b23894a/fnagi-15-1122927-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd2/10040799/71f063d6d824/fnagi-15-1122927-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd2/10040799/34772710543b/fnagi-15-1122927-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd2/10040799/dced02fd4233/fnagi-15-1122927-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd2/10040799/6f6e5b23894a/fnagi-15-1122927-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd2/10040799/71f063d6d824/fnagi-15-1122927-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd2/10040799/34772710543b/fnagi-15-1122927-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dd2/10040799/dced02fd4233/fnagi-15-1122927-g004.jpg

相似文献

1
Classification and prediction of cognitive trajectories of cognitively unimpaired individuals.认知未受损个体认知轨迹的分类与预测
Front Aging Neurosci. 2023 Mar 13;15:1122927. doi: 10.3389/fnagi.2023.1122927. eCollection 2023.
2
Tau levels are higher in objective subtle cognitive decline but not subjective memory complaint.客观认知衰退但无主观记忆主诉者的 Tau 水平更高。
Alzheimers Res Ther. 2022 Aug 22;14(1):114. doi: 10.1186/s13195-022-01060-1.
3
Genetic Moderation of the Association of β-Amyloid With Cognition and MRI Brain Structure in Alzheimer Disease.β-淀粉样蛋白与阿尔茨海默病认知和 MRI 脑结构关联的遗传调节。
Neurology. 2023 Jul 4;101(1):e20-e29. doi: 10.1212/WNL.0000000000207305. Epub 2023 Apr 21.
4
Amyloid-β Positivity Predicts Cognitive Decline but Cognition Predicts Progression to Amyloid-β Positivity.淀粉样蛋白-β 阳性预测认知能力下降,但认知能力预测向淀粉样蛋白-β 阳性进展。
Biol Psychiatry. 2020 May 1;87(9):819-828. doi: 10.1016/j.biopsych.2019.12.021. Epub 2020 Jan 7.
5
Blood Derived Amyloid Biomarkers for Alzheimer's Disease Prevention.用于预防阿尔茨海默病的血液源性淀粉样蛋白生物标志物。
J Prev Alzheimers Dis. 2022;9(1):12-21. doi: 10.14283/jpad.2021.70.
6
Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers.使用血浆生物标志物预测临床前阿尔茨海默病的纵向认知下降。
JAMA Neurol. 2023 Apr 1;80(4):360-369. doi: 10.1001/jamaneurol.2022.5272.
7
Ethnic differences in the prevalence of amyloid positivity and cognitive trajectories.种族差异与淀粉样蛋白阳性率和认知轨迹。
Alzheimers Dement. 2024 Nov;20(11):7556-7566. doi: 10.1002/alz.14247. Epub 2024 Sep 24.
8
Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline.基于经验定义晚年认知和功能衰退轨迹
J Alzheimers Dis. 2016;50(1):271-82. doi: 10.3233/JAD-150563.
9
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.血液磷酸化 tau 181 作为阿尔茨海默病的生物标志物:使用来自四个前瞻性队列的数据进行的诊断性能和预测模型研究。
Lancet Neurol. 2020 May;19(5):422-433. doi: 10.1016/S1474-4422(20)30071-5.
10
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer's disease.预测阿尔茨海默病淀粉样蛋白阳性患者的进展和认知能力下降。
Alzheimers Res Ther. 2021 Sep 6;13(1):151. doi: 10.1186/s13195-021-00886-5.

引用本文的文献

1
Difference in trajectories according to early amyloid accumulation in cognitively unimpaired elderly.认知正常老年人早期淀粉样蛋白沉积轨迹的差异。
Eur J Neurol. 2024 Dec;31(12):e16482. doi: 10.1111/ene.16482. Epub 2024 Sep 14.
2
Characterizing the clinical heterogeneity of early symptomatic Alzheimer's disease: a data-driven machine learning approach.表征早期症状性阿尔茨海默病的临床异质性:一种数据驱动的机器学习方法。
Front Aging Neurosci. 2024 Aug 12;16:1410544. doi: 10.3389/fnagi.2024.1410544. eCollection 2024.
3
A Subtype Perspective on Cognitive Trajectories in Healthy Aging.

本文引用的文献

1
Development of prediction models for distinguishable cognitive trajectories in patients with amyloid positive mild cognitive impairment.淀粉样蛋白阳性轻度认知障碍患者可区分认知轨迹预测模型的开发。
Neurobiol Aging. 2022 Jun;114:84-93. doi: 10.1016/j.neurobiolaging.2022.02.012. Epub 2022 Feb 27.
2
Longitudinal amyloid cognitive composite in preclinical Alzheimer's disease.临床前阿尔茨海默病中的纵向淀粉样蛋白认知综合指标。
Eur J Neurol. 2022 Apr;29(4):980-989. doi: 10.1111/ene.15241. Epub 2022 Jan 26.
3
Facilitating Growth Mixture Model Convergence in Preventive Interventions.
健康老龄化认知轨迹的亚型视角
Brain Sci. 2024 Apr 1;14(4):351. doi: 10.3390/brainsci14040351.
促进预防干预中增长混合模型的收敛。
Prev Sci. 2023 Apr;24(3):505-516. doi: 10.1007/s11121-021-01262-3. Epub 2021 Jul 7.
4
Trajectory Modelling Techniques Useful to Epidemiological Research: A Comparative Narrative Review of Approaches.对流行病学研究有用的轨迹建模技术:方法的比较叙述性综述
Clin Epidemiol. 2020 Oct 30;12:1205-1222. doi: 10.2147/CLEP.S265287. eCollection 2020.
5
Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and early mild cognitive impairment.载脂蛋白 E4 在主观记忆障碍和早期轻度认知障碍中的分布及其临床影响。
Sci Rep. 2020 Aug 7;10(1):13365. doi: 10.1038/s41598-020-69603-w.
6
Normative Cognitive Decline in Old Age.老年的正常认知衰退。
Ann Neurol. 2020 Jun;87(6):816-829. doi: 10.1002/ana.25711. Epub 2020 Mar 14.
7
A new Centiloid method for F-florbetaben and F-flutemetamol PET without conversion to PiB.一种用于F-氟贝他班和F-氟代甲磺酸美他莫尔PET的新的百分制方法,无需转换为匹兹堡化合物B。
Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1938-1948. doi: 10.1007/s00259-019-04596-x. Epub 2019 Dec 13.
8
Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.淀粉样β阳性在可能有脑淀粉样血管病标志物的患者中的临床意义。
Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1287-1298. doi: 10.1007/s00259-019-04314-7. Epub 2019 Apr 2.
9
A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment.用于预测遗忘型轻度认知障碍淀粉样 PET 阳性的列线图。
J Alzheimers Dis. 2018;66(2):681-691. doi: 10.3233/JAD-180048.
10
Prediction Models of Cognitive Trajectories in Patients with Nonamnestic Mild Cognitive Impairment.非遗忘型轻度认知障碍患者认知轨迹的预测模型。
Sci Rep. 2018 Jul 11;8(1):10468. doi: 10.1038/s41598-018-28881-1.